A listing of Squamous Cell Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This is a phase 3 randomized, open-label study to evaluate the efficacy and safety of petosemtamab plus pembrolizumab vs pembrolizumab for the first-line (1L) treatment of recurrent or metastatic, programmed cell death protein ligand 1+ (PD-L1+) head and neck squamous cell carcinoma (HNSCC) in patients with combined positive score (CPS) …